Soiken Holdings Inc. (TYO:2385)
Japan · Delayed Price · Currency is JPY 215.00
+1.00 (0.47%)
Jul 16, 2026, 9:54 AM JST
Soiken Holdings Market Cap
Soiken Holdings has a market cap or net worth of 5.6 billion as of July 15, 2026. Its market cap has increased by 22.99% in one year.
Market Cap
5.60B
Enterprise Value
-45.15M
Revenue
4.40B
Ranking
n/a
PE Ratio
30.42
Stock Price
215.00
Market Cap Chart
Since December 19, 2003, Soiken Holdings's market cap has decreased from 71.34B to 5.60B, a decrease of -92.15%. That is a compound annual growth rate of -10.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 5.60B | -8.94% |
| Dec 30, 2025 | 6.15B | 97.48% |
| Dec 30, 2024 | 3.11B | -29.17% |
| Dec 29, 2023 | 4.39B | -39.13% |
| Dec 30, 2022 | 7.22B | -12.93% |
| Dec 30, 2021 | 8.29B | -49.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADR Biomedical Holdings | 7.15B |
| MEDINET | 7.00B |
| Carna Biosciences | 6.96B |
| BrightPath Biotherapeutics | 6.94B |
| CellSource | 6.93B |
| Noile-Immune Biotech | 5.82B |
| PRISM BioLab Co.,LTD | 5.69B |
| Chiome Bioscience | 5.66B |